News Service

late-breaking news in healthcare

FDA News Briefs for Monday, July 30, 2018

July 30, 2018

These Food and Drug Administration (FDA) developments came in late last week:

 

FDA Grants De Novo Marketing Clearance for Bonebridge Hearing Implant System

The FDA has granted de novo marketing clearance for the Bonebridge bone conducting hearing implant system (Med-El USA). The system is indicated for individuals aged 12 years and older with conductive hearing loss, mixed hearing loss, or single-sided deafness. More Information.

 

FDA Update on Valsartan Recalls

The FDA has issued an update regarding recalled valsartan-containing products. Not all products containing valsartan are being recalled; this update clarifies which valsartan-containing products are being recalled. More Information.